- Investing Ideas
- South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential
South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
2 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
ALTEOGEN
Market Cap: ₩19.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩369,500.00
7D
-0.1%
1Y
-1.7%
Samsung Epis Holdings
Market Cap: ₩15.2t
A biotechnology company, manage the portfolio of biopharmaceutical products.
New
A0126Z0
₩609,000.00
7D
17.8%
1Y
n/a
Celltrion
Market Cap: ₩43.8t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
New
A068270
₩209,000.00
7D
3.7%
1Y
36.5%